Because GLP-1 medications reduce appetite and help people eat less, some patients may struggle to consume enough protein and calories to support muscle maintenance
Consider adding Emerald Laser Body Sculpting for stubborn areas resistant to diet and medication
There's no standardized microdosing protocol yet that's part of why this conversation is still emerging
For context, licensed GLP-1 receptor agonists used in weight management such as semaglutide 2.4 mg (Wegovy) cost in the region of 200300 per month when prescribed privately in the UK (indicative figures as of mid-2025
Journal reference: Gasoyan, H., Schulte, R., Boyer, C
Where it works: Adipose tissue (fat cells): Reduces inflammation and may improve fat metabolism Pancreas: Works alongside GLP-1 to enhance insulin secretion Brain: May contribute to appetite regulation (research ongoing) Weight loss contribution: When GIP is added to GLP-1 (as in tirzepatide), weight loss increases from ~15% to ~22%